Cargando…
Value of (68)Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [(18)F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study
OBJECTIVES: The bombesin derivative RM2 is a GRPr antagonist with strong binding affinity to prostate cancer (PCa). In this study, the impact of [(68)Ga]Ga-RM2 positron emission tomography-computed tomography (PET-CT) for the detection of primary PCa was compared with that of [(18)F]FCH PET-CT and m...
Autores principales: | Beheshti, Mohsen, Taimen, Pekka, Kemppainen, Jukka, Jambor, Ivan, Müller, Andre, Loidl, Wolfgang, Kähkönen, Esa, Käkelä, Meeri, Berndt, Mathias, Stephens, Andrew W., Minn, Heikki, Langsteger, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755087/ https://www.ncbi.nlm.nih.gov/pubmed/35864350 http://dx.doi.org/10.1007/s00330-022-08982-2 |
Ejemplares similares
-
Role of radiomic analysis of [(18)F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging
por: Marturano, Francesca, et al.
Publicado: (2023) -
The primacy of multiparametric MRI in men with suspected prostate cancer
por: Richenberg, Jonathan, et al.
Publicado: (2019) -
Multiparametric dynamic contrast-enhanced ultrasound imaging of prostate cancer
por: Wildeboer, Rogier R., et al.
Publicado: (2016) -
3D T2-weighted imaging to shorten multiparametric prostate MRI protocols
por: Polanec, Stephan H., et al.
Publicado: (2017) -
Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy
por: Hansen, Nienke L., et al.
Publicado: (2016)